19th Jun 2020 16:25
Catenae Innovation PLC - digital media and technology - Says partner Newcastle Premier Health Ltd completes proof of concept of Catenae's Cov-ID app, intended as a Covid-19 virus infection verification passport. The app will allow users to prove their Covid-19 status in a secure and data-protection compliant manner. The proof of concept stage was positive, but Catenae warns there is no guarantee the app will be commercialised or, if it is, will bring material revenue to the company.
Current stock price: 2.88 pence, down 18% on day
Year-to-date change: up more than 100%, 1.10p on January 2
By Tom Waite; [email protected]
Copyright 2020 Alliance News Limited. All Rights Reserved.
Related Shares:
CTEA.L